Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
about
Pharmacometabolomics of response to sertraline and to placebo in major depressive disorder - possible role for methoxyindole pathwayAssociations between purine metabolites and clinical symptoms in schizophreniaMetabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomicsHomeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophreniaBiomarkers of Parkinson's disease: present and futureProtein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseasesNeuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesOmics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric DisordersMetabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolitesMetabolomics of human brain aging and age-related neurodegenerative diseasesBiochemical premotor biomarkers for Parkinson's diseaseEmerging candidate biomarkers for Parkinson's disease: a reviewIdentification of key uric acid synthesis pathway in a unique mutant silkworm Bombyx mori model of Parkinson's diseasePlasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to TreatmentMetabolomic biomarkers as strong correlates of Parkinson disease progressionMetabolomics and the search for biomarkers in Parkinson's diseaseDJ-1 isoforms in whole blood as potential biomarkers of Parkinson diseaseMetabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions.The role of biomarkers and imaging in Parkinson's disease.Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Metabolomic profiling in LRRK2-related Parkinson's diseaseMicroextraction by Packed Sorbent (MEPS) and Solid-Phase Microextraction (SPME) as Sample Preparation Procedures for the Metabolomic Profiling of Urine.Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis.Insulin sensitivity is reflected by characteristic metabolic fingerprints--a Fourier transform mass spectrometric non-targeted metabolomics approachBlood-based biomarkers for Parkinson's disease(1)H NMR-based metabolic profiling reveals inherent biological variation in yeast and nematode model systems.metabolic profiling of Parkinson's disease and mild cognitive impairment.Biomarkers for cognitive impairment in Parkinson disease.Reduced creatine kinase as a central and peripheral biomarker in Huntington's diseaseMetabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traitsCSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease.Cross-platform analysis of longitudinal data in metabolomics.Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease.Advances in NMR-based biofluid analysis and metabolite profilingAltered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.Unbiased approaches to biomarker discovery in neurodegenerative diseasesMetabolomic changes in autopsy-confirmed Alzheimer's diseaseCirculating miRNA biomarkers for Alzheimer's diseasePlasma metabolomic profiling of dairy cows affected with ketosis using gas chromatography/mass spectrometry.
P2860
Q21559605-3E07D4DC-F53A-43DD-B04A-B7E322082B5AQ21560779-80E7BBAB-A761-4B47-AE22-97D160968F67Q21560953-AF916A7A-A1EE-4C01-9848-0FE0998366ECQ21562668-57850709-9B81-49F5-B05C-F6FAD21EBABBQ24170134-7496C414-A4E0-4771-B91B-399D6523039FQ24650014-783C5B5B-53FE-4D72-9520-319F2F66E083Q26747508-770792BE-822E-404C-B913-449E334671E0Q26784904-81160B59-BDF6-4D6D-9808-3594643A194AQ26824720-620D868C-9824-43B9-934D-60D25F82244BQ26992344-5B2E55AD-8CF5-41FA-A93F-666761280F02Q27008467-CA5A491D-9A8F-4EBB-AE01-30BB2FA10893Q27015018-7CDA9415-586E-405F-ADB9-CC76D16A60F3Q27311266-5D183279-C4BA-49B9-A015-8F57C16E8114Q28587923-9B0B9D03-AA37-48F1-92A7-E0F2F3F7D52BQ29248111-B191D153-A05F-48A0-BE55-DB208252F35EQ30410511-7DF71377-0C6C-43EA-9666-A0D98501A668Q30529658-0428AF20-264E-4987-B9D2-7BAF3ACD9C19Q30885784-F0350440-ACE4-41DC-936D-0AE762848913Q31041660-BCF0827D-4EF9-4F8D-B647-B001E5AEDB1FQ33350202-86E5B6C1-DE8D-48DE-A0B7-87CFBC4EE44BQ33511761-8FB6EF3C-A95A-4053-876F-CC828C07ADF1Q33601018-D78259EC-8DAE-45FB-9423-9BCE00750FC8Q33699851-85B370CE-D052-4AF1-81C9-93F3B36B80D7Q33728538-C32ACCC4-31C4-4116-860C-EE98B4F8C129Q33804255-F1D664A2-7077-4076-B1BB-D6EA2674313DQ33829694-32D04FC4-2C88-4EE9-A45C-DD8293FF1373Q33835701-A1F0AF61-AA65-49D4-B35F-F8915C95CF34Q33896664-E51A6A0E-8124-4915-98C2-B403A576B9BEQ33945688-C91DABEF-F666-4926-A09B-CD8206F07A2CQ33970039-9EB801D8-5CF0-40D9-8DBC-5E92524A9AAFQ33994583-7A9E870F-485A-43F2-9E5B-2CD2C5200202Q34030471-3E7EC72B-D85D-482F-A9E1-20109FC371DBQ34032608-744F92C4-D270-4329-96C6-DFB36370F7F8Q34109340-AAE93439-F154-471D-9FC5-FED17566493BQ34192207-BC60DCCC-D5DD-44B5-878E-99002F9BB98EQ34351848-0678750C-9A77-4920-8757-885DB96BD877Q34625918-5E8439BE-0BD2-4959-89AA-3B86819A05E1Q34700264-2FA6EDA9-A2F2-4254-9328-CFB84A1C08ADQ34904013-DAA8B4D8-754E-44A6-8C48-E28CBF230C08Q34999949-C060FBA8-7218-4096-954C-C292E6893105
P2860
Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
@en
Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
@nl
type
label
Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
@en
Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
@nl
prefLabel
Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
@en
Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
@nl
P2093
P356
P1433
P1476
Metabolomic profiling to develop blood biomarkers for Parkinson's disease.
@en
P2093
M Flint Beal
Mikhail Bogdanov
Susan S Bressman
Theodore Matson
Wayne R Matson
P304
P356
10.1093/BRAIN/AWM304
P407
P577
2008-02-01T00:00:00Z